Ciprofloxacin: an updated review of its pharmacology, therapeutic efficacy and tolerability

R Davis, A Markham, JA Balfour - Drugs, 1996 - Springer
Ciprofloxacin is a broad spectrum fluoroquinolone antibacterial agent. Since its introduction
in the 1980s, most Gram-negative bacteria have remained highly susceptible to this agent in …

Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial

A Uranga, PP España, A Bilbao… - JAMA internal …, 2016 - jamanetwork.com
Importance The optimal duration of antibiotic treatment for community-acquired pneumonia
(CAP) has not been well established. Objective To validate Infectious Diseases Society of …

Chronic respiratory infection in patients with chronic obstructive pulmonary disease: what is the role of antibiotics?

M Miravitlles, A Anzueto - International journal of molecular sciences, 2017 - mdpi.com
Chronic infections are associated with exacerbation in patients with chronic obstructive
pulmonary disease (COPD). The major objective of the management of these patients is the …

Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome

I April - Jama, 2009 - jamanetwork.com
Context The novel influenza A (H1N1) pandemic affected Australia and New Zealand during
the 2009 southern hemisphere winter. It caused an epidemic of critical illness and some …

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial

D Snijders, JMA Daniels, CS de Graaff… - American journal of …, 2010 - atsjournals.org
Rationale: Some studies have shown a beneficial effect of corticosteroids in patients with
community-acquired pneumonia (CAP), possibly by diminishing local and systemic …

Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa

AR Hauser, E Cobb, M Bodí, D Mariscal… - Critical care …, 2002 - journals.lww.com
Objective Pseudomonas aeruginosa is a frequent cause of ventilator-associated
pneumonia. Recent evidence suggests that production of type III secretion proteins is …

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double …

R el Moussaoui, CAJM De Borgie, P Van den Broek… - 2006 - bmj.com
Objective To compare the effectiveness of discontinuing treatment with amoxicillin after three
days or eight days in adults admitted to hospital with mild to moderate-severe community …

The value of routine microbial investigation in ventilator-associated pneumonia

J Rello, M Gallego, D Mariscal, R Sonora… - American journal of …, 1997 - atsjournals.org
The use of microbiologic investigations in routine clinical practice, their value in guiding
antibiotic prescription, and their influence on outcome were prospectively studied in 113 …

Pharmacodynamics of cefepime in patients with Gram-negative infections

VH Tam, PS McKinnon, RL Akins… - Journal of …, 2002 - academic.oup.com
We conducted a prospective, open-label study to delineate a relationship between exposure
and outcomes in 36 patients treated with cefepime. Twenty patients had documented Gram …

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem …

MP Fink, DR Snydman, MS Niederman… - Antimicrobial agents …, 1994 - Am Soc Microbiol
Intravenously administered ciprofloxacin was compared with imipenem for the treatment of
severe pneumonia. In this prospective, randomized, double-blind, multicenter trial, which …